Literature DB >> 9159307

Familial clustering of end-stage renal disease in blacks with lupus nephritis.

B I Freedman1, C H Wilson, B J Spray, A B Tuttle, I M Olorenshaw, G M Kammer.   

Abstract

The factors that determine a patient's susceptibility to specific target organ involvement in systemic lupus erythematosus (SLE) remain unknown. Lupus nephritis can be a particularly devastating complication, with an increased mortality and the risk of progressive renal damage resulting in end-stage renal disease (ESRD). This analysis was performed to determine whether renal disease aggregated in select families or was a sporadic complication in patients with SLE. We compared the family history of ESRD in 50 patients with SLE complicated by lupus nephritis with 37 controls who had SLE but lacked nephritis after a mean follow-up duration of more than 11 years. The frequency of relatives with ESRD in the lupus nephritis cases was compared with that in controls using Fisher's exact test (significance at P < or = 0.05). Fifty percent (25) of the 50 lupus nephritis patients were black and 50% (25) white, in contrast to 35% (13) and 65% (24) of the 37 lupus non-nephropathy controls, respectively. A first-, second-, or third-degree relative with ESRD was present in 16% (eight) of the 50 lupus nephritis cases and in 0% of the 37 SLE non-nephropathy controls (P = 0.019, Fisher's exact test, two-tail). Twenty-eight percent (seven) of the 25 black patients with lupus nephritis had relatives with ESRD compared with 0% of the 13 black lupus non-nephritis controls (P = 0.07). Only one of the eight relatives with ESRD had SLE or a collagen vascular disease. Lupus nephritis patients and the non-nephritis controls had similar ages (mean +/- SD: 38.5 +/- 10.0 years v 46.6 +/- 11.8 years; P = 0.28), family sizes (6.27 +/- 2.61 first-degree relatives v 6.35 +/- 3.25 first-degree relatives; P = 0.16), and duration of SLE (9.26 +/- 5.94 years v 11.35 +/- 6.43 years; P = 0.60). Familial clustering of ESRD was observed in black patients with SLE who had nephritis. This was unlikely to be related to differences in patient age, family size, or duration of SLE. This data, coupled with the known familial aggregation of ESRD in blacks with hypertensive and diabetic ESRD, supports the contention that genetic factors contribute to the familial clustering. The presence of relatives with etiologies of ESRD other than SLE suggests that there is an inherited susceptibility to progressive renal failure, independent of the etiology of ESRD.

Entities:  

Mesh:

Year:  1997        PMID: 9159307     DOI: 10.1016/s0272-6386(97)90126-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  20 in total

1.  Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis.

Authors:  Paula S Ramos; Elisabeth E Brown; Robert P Kimberly; Carl D Langefeld
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

Review 2.  The spectrum of MYH9-associated nephropathy.

Authors:  Meredith A Bostrom; Barry I Freedman
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

3.  The non-muscle Myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans.

Authors:  Barry I Freedman; Jeffrey C Edberg; Mary E Comeau; Mariana Murea; Donald W Bowden; Jasmin Divers; Graciela S Alarcón; Elizabeth E Brown; Gerald McGwin; Jeffrey B Kopp; Cheryl A Winkler; George W Nelson; Gabor Illei; Michelle Petri; Rosalind Ramsey-Goldman; John D Reveille; Luis M Vilá; Carl D Langefeld; Robert P Kimberly
Journal:  Am J Nephrol       Date:  2010-06-07       Impact factor: 3.754

4.  End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.

Authors:  Barry I Freedman; Carl D Langefeld; Kelly K Andringa; Jennifer A Croker; Adrienne H Williams; Neva E Garner; Daniel J Birmingham; Lee A Hebert; Pamela J Hicks; Mark S Segal; Jeffrey C Edberg; Elizabeth E Brown; Graciela S Alarcón; Karen H Costenbader; Mary E Comeau; Lindsey A Criswell; John B Harley; Judith A James; Diane L Kamen; S Sam Lim; Joan T Merrill; Kathy L Sivils; Timothy B Niewold; Neha M Patel; Michelle Petri; Rosalind Ramsey-Goldman; John D Reveille; Jane E Salmon; Betty P Tsao; Keisha L Gibson; Joyce R Byers; Anna K Vinnikova; Janice P Lea; Bruce A Julian; Robert P Kimberly
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

5.  Whole-Exome Sequencing in Adults With Chronic Kidney Disease: A Pilot Study.

Authors:  Sneh Lata; Maddalena Marasa; Yifu Li; David A Fasel; Emily Groopman; Vaidehi Jobanputra; Hila Rasouly; Adele Mitrotti; Rik Westland; Miguel Verbitsky; Jordan Nestor; Lindsey M Slater; Vivette D'Agati; Marcin Zaniew; Anna Materna-Kiryluk; Francesca Lugani; Gianluca Caridi; Luca Rampoldi; Aditya Mattoo; Chad A Newton; Maya K Rao; Jai Radhakrishnan; Wooin Ahn; Pietro A Canetta; Andrew S Bomback; Gerald B Appel; Corinne Antignac; Glen S Markowitz; Christine K Garcia; Krzysztof Kiryluk; Simone Sanna-Cherchi; Ali G Gharavi
Journal:  Ann Intern Med       Date:  2017-12-05       Impact factor: 25.391

Review 6.  Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.

Authors:  Barry I Freedman; Karl Skorecki
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-05       Impact factor: 8.237

Review 7.  Genetics of human lupus nephritis.

Authors:  Taro Iwamoto; Timothy B Niewold
Journal:  Clin Immunol       Date:  2016-09-28       Impact factor: 3.969

8.  The association of cell cycle checkpoint 2 variants and kidney function: findings of the Family Blood Pressure Program and the Atherosclerosis Risk In Communities study.

Authors:  Nora Franceschini; Kari E North; Donna Arnett; James S Pankow; Jay H Chung; Lisa Baird; Mark F Leppert; John H Eckfeldt; Eric Boerwinkle; C Charles Gu; Cora E Lewis; Richard H Myers; Stephen T Turner; Alan Weder; W H Linda Kao; Thomas H Mosley; Aravinda Chakravarti; Holly Kramer; Jinghui Zhang; Steven C Hunt
Journal:  Am J Hypertens       Date:  2009-03-05       Impact factor: 2.689

Review 9.  APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD.

Authors:  Barry I Freedman; Sophie Limou; Lijun Ma; Jeffrey B Kopp
Journal:  Am J Kidney Dis       Date:  2018-11       Impact factor: 8.860

10.  Predictors of the start of declining eGFR in patients with systemic lupus erythematosus.

Authors:  Terry Cheuk-Fung Yip; Suchi Saria; Michelle Petri; Laurence S Magder
Journal:  Lupus       Date:  2020-10-28       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.